Concepts (126)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myocytes, Cardiac | 13 | 2026 | 121 | 2.830 |
Why?
|
| Induced Pluripotent Stem Cells | 10 | 2026 | 159 | 1.330 |
Why?
|
| Myocardium | 8 | 2023 | 299 | 1.030 |
Why?
|
| Lab-On-A-Chip Devices | 9 | 2024 | 26 | 1.030 |
Why?
|
| Tissue Engineering | 8 | 2024 | 147 | 1.000 |
Why?
|
| Angiotensin II | 2 | 2024 | 25 | 0.900 |
Why?
|
| Vaccines | 1 | 2023 | 96 | 0.730 |
Why?
|
| Autophagy | 2 | 2013 | 232 | 0.650 |
Why?
|
| Cardiomyopathies | 1 | 2021 | 131 | 0.610 |
Why?
|
| Heart Diseases | 1 | 2022 | 222 | 0.600 |
Why?
|
| Nanoparticles | 2 | 2026 | 544 | 0.560 |
Why?
|
| Drug Evaluation, Preclinical | 4 | 2021 | 95 | 0.470 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2013 | 312 | 0.410 |
Why?
|
| Animals, Newborn | 1 | 2013 | 241 | 0.380 |
Why?
|
| Fibrosis | 3 | 2022 | 171 | 0.370 |
Why?
|
| Transcriptional Activation | 1 | 2013 | 197 | 0.370 |
Why?
|
| Cell Culture Techniques | 2 | 2026 | 195 | 0.350 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2013 | 344 | 0.340 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2013 | 661 | 0.300 |
Why?
|
| Proteomics | 2 | 2021 | 291 | 0.290 |
Why?
|
| Drug Discovery | 2 | 2020 | 95 | 0.280 |
Why?
|
| Adjuvants, Immunologic | 2 | 2026 | 235 | 0.270 |
Why?
|
| Coculture Techniques | 3 | 2026 | 103 | 0.260 |
Why?
|
| Membrane Proteins | 1 | 2013 | 922 | 0.260 |
Why?
|
| Poliovirus Vaccine, Inactivated | 1 | 2026 | 4 | 0.250 |
Why?
|
| Poliomyelitis | 1 | 2026 | 5 | 0.250 |
Why?
|
| Immunity, Mucosal | 1 | 2026 | 54 | 0.240 |
Why?
|
| Microtechnology | 2 | 2023 | 6 | 0.240 |
Why?
|
| Culture Media | 1 | 2026 | 79 | 0.240 |
Why?
|
| Humans | 23 | 2026 | 64770 | 0.230 |
Why?
|
| Organoids | 2 | 2024 | 41 | 0.220 |
Why?
|
| Needles | 1 | 2025 | 64 | 0.210 |
Why?
|
| Heart Failure | 1 | 2012 | 944 | 0.210 |
Why?
|
| Zeolites | 1 | 2024 | 3 | 0.210 |
Why?
|
| Intestinal Mucosa | 1 | 2026 | 250 | 0.210 |
Why?
|
| RNA, Messenger | 2 | 2025 | 1572 | 0.210 |
Why?
|
| Cardiac Myosins | 1 | 2024 | 24 | 0.210 |
Why?
|
| Myosin Heavy Chains | 1 | 2024 | 45 | 0.210 |
Why?
|
| Proteome | 2 | 2021 | 151 | 0.200 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2023 | 39 | 0.200 |
Why?
|
| Models, Cardiovascular | 3 | 2018 | 83 | 0.190 |
Why?
|
| Heart | 2 | 2024 | 297 | 0.180 |
Why?
|
| Animals | 9 | 2026 | 21309 | 0.180 |
Why?
|
| Relaxin | 1 | 2021 | 2 | 0.180 |
Why?
|
| Losartan | 1 | 2021 | 19 | 0.170 |
Why?
|
| Signal Transduction | 3 | 2020 | 3148 | 0.170 |
Why?
|
| Cardiotonic Agents | 1 | 2021 | 54 | 0.170 |
Why?
|
| Perfusion | 1 | 2021 | 74 | 0.170 |
Why?
|
| Vaccination | 1 | 2023 | 374 | 0.170 |
Why?
|
| Cells, Cultured | 4 | 2026 | 2188 | 0.170 |
Why?
|
| Ventricular Remodeling | 1 | 2021 | 90 | 0.170 |
Why?
|
| Blood Vessels | 1 | 2021 | 63 | 0.170 |
Why?
|
| Algorithms | 1 | 2026 | 1033 | 0.160 |
Why?
|
| Drug Delivery Systems | 1 | 2023 | 334 | 0.160 |
Why?
|
| Cell Line | 2 | 2021 | 2036 | 0.150 |
Why?
|
| Tissue Scaffolds | 4 | 2024 | 90 | 0.150 |
Why?
|
| Cell Survival | 1 | 2021 | 581 | 0.150 |
Why?
|
| Organ Culture Techniques | 1 | 2019 | 62 | 0.150 |
Why?
|
| Fibroblasts | 1 | 2021 | 414 | 0.150 |
Why?
|
| Recombinant Proteins | 1 | 2021 | 710 | 0.150 |
Why?
|
| Tissue Culture Techniques | 1 | 2019 | 33 | 0.150 |
Why?
|
| Pandemics | 1 | 2023 | 669 | 0.140 |
Why?
|
| Embryonic Stem Cells | 1 | 2019 | 156 | 0.140 |
Why?
|
| Pilot Projects | 1 | 2021 | 1002 | 0.130 |
Why?
|
| Cardiomyopathy, Hypertrophic | 2 | 2024 | 791 | 0.130 |
Why?
|
| Rats | 2 | 2026 | 1996 | 0.120 |
Why?
|
| Mice | 3 | 2021 | 11100 | 0.120 |
Why?
|
| Disease Models, Animal | 3 | 2020 | 2277 | 0.100 |
Why?
|
| Apoptosis | 2 | 2024 | 1094 | 0.100 |
Why?
|
| Mitochondria, Heart | 1 | 2013 | 13 | 0.100 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2013 | 30 | 0.100 |
Why?
|
| Cell Hypoxia | 1 | 2013 | 42 | 0.100 |
Why?
|
| Myocardial Ischemia | 1 | 2013 | 117 | 0.090 |
Why?
|
| Mitochondrial Proteins | 1 | 2013 | 108 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2012 | 104 | 0.090 |
Why?
|
| Cell Differentiation | 3 | 2026 | 1382 | 0.090 |
Why?
|
| Blotting, Western | 1 | 2013 | 610 | 0.090 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2013 | 623 | 0.090 |
Why?
|
| Microscopy, Fluorescence | 1 | 2013 | 403 | 0.090 |
Why?
|
| Lysosomes | 1 | 2012 | 171 | 0.090 |
Why?
|
| Cardiovascular Diseases | 1 | 2018 | 861 | 0.080 |
Why?
|
| Liposomes | 1 | 2026 | 116 | 0.060 |
Why?
|
| Immunization | 1 | 2026 | 136 | 0.060 |
Why?
|
| Immunoglobulin A | 1 | 2026 | 102 | 0.060 |
Why?
|
| Lymph Nodes | 1 | 2026 | 231 | 0.060 |
Why?
|
| Injections, Intradermal | 1 | 2025 | 12 | 0.060 |
Why?
|
| Microinjections | 1 | 2025 | 68 | 0.060 |
Why?
|
| Sarcomeres | 1 | 2024 | 51 | 0.050 |
Why?
|
| Swine | 1 | 2025 | 395 | 0.050 |
Why?
|
| Extracellular Vesicles | 1 | 2024 | 46 | 0.050 |
Why?
|
| NAV1.5 Voltage-Gated Sodium Channel | 1 | 2023 | 6 | 0.050 |
Why?
|
| Lipids | 1 | 2026 | 327 | 0.050 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2024 | 115 | 0.050 |
Why?
|
| Microfluidics | 1 | 2023 | 25 | 0.050 |
Why?
|
| Myosins | 1 | 2024 | 117 | 0.050 |
Why?
|
| Endosomes | 1 | 2024 | 181 | 0.050 |
Why?
|
| Calcium | 1 | 2026 | 583 | 0.050 |
Why?
|
| Biocompatible Materials | 1 | 2023 | 153 | 0.050 |
Why?
|
| Genotype | 1 | 2024 | 670 | 0.050 |
Why?
|
| Toll-Like Receptors | 1 | 2024 | 435 | 0.040 |
Why?
|
| Endothelial Cells | 1 | 2023 | 205 | 0.040 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2021 | 43 | 0.040 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2020 | 46 | 0.040 |
Why?
|
| Cytokines | 1 | 2024 | 953 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2024 | 718 | 0.040 |
Why?
|
| Dimethylpolysiloxanes | 1 | 2019 | 13 | 0.040 |
Why?
|
| Electrophysiological Phenomena | 1 | 2019 | 22 | 0.040 |
Why?
|
| Phosphoproteins | 1 | 2020 | 223 | 0.040 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2020 | 198 | 0.040 |
Why?
|
| Polystyrenes | 1 | 2019 | 35 | 0.040 |
Why?
|
| Elastic Modulus | 1 | 2019 | 39 | 0.040 |
Why?
|
| Action Potentials | 1 | 2019 | 112 | 0.040 |
Why?
|
| Pluripotent Stem Cells | 1 | 2019 | 72 | 0.040 |
Why?
|
| Liver | 1 | 2023 | 867 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2020 | 960 | 0.030 |
Why?
|
| MicroRNAs | 1 | 2024 | 704 | 0.030 |
Why?
|
| Physical Stimulation | 1 | 2017 | 30 | 0.030 |
Why?
|
| Equipment Design | 1 | 2018 | 359 | 0.030 |
Why?
|
| Electric Stimulation | 1 | 2017 | 139 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2018 | 479 | 0.030 |
Why?
|
| Hydrogels | 1 | 2017 | 125 | 0.030 |
Why?
|
| Child | 1 | 2024 | 4598 | 0.030 |
Why?
|
| Models, Biological | 1 | 2019 | 1203 | 0.030 |
Why?
|
| Female | 2 | 2026 | 33762 | 0.020 |
Why?
|
| Adult | 1 | 2023 | 17239 | 0.010 |
Why?
|
| Male | 1 | 2024 | 30809 | 0.010 |
Why?
|